Mutations involving TGFB and MAPK may be associated with malignancy in granular cell tumors.

Carina A Dehner, Tyler Moon, Yang Lyu, Xiaochun Zhang, Zhaohe Zhou, Kuangying Yang, John S A Chrisinger, Anthony Griffin, Jay Wunder, Brendan C Dickson, Angela C Hirbe

Genes, chromosomes & cancer 2023 May

filter terms:

Granular cell tumors (GrCTs) are mesenchymal neoplasms of presumed schwannian differentiation that may present as solitary or multifocal lesions with excision usually being curative. A minority of cases, however, show histological features associated with an increased risk for metastasis and are highly aggressive leading to death in about a third of cases. While benign and malignant cases have been shown to harbor mutations in the H + ATPase genes, there is only limited data examining molecular aberrations associated with malignancy. The departmental archives were searched for cases of atypical/malignant GrCTs. Clinical and histopathological features were noted. Whole-exome sequencing was performed. Three cases of malignant GrCTs and one case of atypical GrCTs were included. All three malignant tumors metastasized to distant sites with a median disease-free survival of 16 months and an overall follow-up time of 35 months. Whole-exome sequencing showed mutations involving TGFβ and MAPK pathways in all four tumors. Although the cohort size is small, our preliminary findings suggest that mutations involving the TGFβ and MAPK pathways may be associated with tumor progression or malignant transformation in GrCT pathogenesis. © 2023 The Authors. Genes, Chromosomes and Cancer published by Wiley Periodicals LLC.

Citation

Carina A Dehner, Tyler Moon, Yang Lyu, Xiaochun Zhang, Zhaohe Zhou, Kuangying Yang, John S A Chrisinger, Anthony Griffin, Jay Wunder, Brendan C Dickson, Angela C Hirbe. Mutations involving TGFB and MAPK may be associated with malignancy in granular cell tumors. Genes, chromosomes & cancer. 2023 May;62(5):301-307